v3.26.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (49,543,537) $ 6,928,242
Adjustments to reconcile net loss to net cash used in operating activities:    
Reversal of credit loss allowance for accounts receivable 0 (7,504,925)
Impairment loss for advances to suppliers 14,341,141 125,639
Credit loss allowance for acquisition reversal receivable 33,151,699 0
Reversal of credit loss allowance for prepaid expenses and other current assets 0 (9,074)
Reversal of credit loss allowance for inventories 0 (297,183)
Depreciation expense 239,213 248,076
Amortization of operating lease right-of-use assets 30,860 56,367
Amortization of intangible assets and land use right 0 99,670
Depreciation of biological assets 0 464,696
Gain on disposal of subsidiaries 0 (824,512)
Share of net loss from equity investee 610,336 0
Amortization of debts issuance costs 70,982 0
Interest expenses 814,928 54,738
Changes in operating assets and liabilities:    
Accounts receivable, net (2,294,503) (7,461,178)
Inventories, net (1,077,920) 1,447,226
Advances to suppliers, net 2,394,149 4,765,300
Prepaid expenses and other current assets (35,400) 126,553
Accounts payable 85,762 297,446
Taxes payable 18 2,497
Accrued expenses and other current liabilities (24,519) 23,104
Net cash used in operating activities (1,236,791) (1,457,318)
Cash flows from investing activities:    
Proceeds from disposal of subsidiaries, net of cash 0 (3,979)
Loan to a third party (5,974,572) (2,296,372)
Repayment from loan to a third party 6,102,196 0
Advances to a related party (624,723) 0
Net cash used in investing activities (497,099) (2,300,351)
Cash flows from financing activities:    
Proceeds from convertible notes 7,000,000 3,149,750
Proceeds from issuance of shares and warrants 0 523,200
Net cash provided by financing activities 7,000,000 3,672,950
Effect of exchange rate changes on cash 1,182 (1,157)
Net increase (decrease) in cash 5,267,292 (85,876)
Cash and restricted cash, beginning of period 390,706 317,323
Cash and restricted cash, end of period 5,657,998 231,447
Representing:    
Cash, end of period 130,474 231,447
Restricted cash, end of period 5,527,524 0
Total cash and restricted cash, end of period 5,657,998 231,447
Supplemental disclosure of cash flow information:    
Cash paid for income tax 0 334
Cash paid for interest 0 0
Supplemental disclosure of non-cash information:    
Issuance of shares for acquisition 2,000,000 0
Issuance of ordinary shares for convertible notes redemption $ 3,010,270 $ 2,760,000